{"id":433024,"title":"Special Access Program for drugs: Guidance document for industry and practitioners - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:25:54.279000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/drugs/guidance.html?wbdisable=true","snippet":"Special Access Program for drugs: Guidance document for industry and practitioners Download the alternative format (PDF format, 397 KB, 29 pages) Date published: 2020-10-14 Revised date: 2022-04-11 This guidance document explains the regulatory information requirements and…","rawSnapshotUrl":"/api/snapshots/raw/433024","browseUrl":"https://replay.healtharchive.ca/job-6/20260102092554/https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/drugs/guidance.html?wbdisable=true#ha_snapshot=433024","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}